Skip to main content
View expanded cover

Vitamin D Analogs in Cancer Prevention and Therapy pp 247–257Cite as

Short-Chain Fatty Acids and Colon Cancer Cells: The Vitamin D Receptor—Butyrate Connection

  • Conference paper

Part of the Recent Results in Cancer Research book series (RECENTCANCER,volume 164)

Abstract

Butyrate and its prodrug tributyrin, as well as 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3), have important physiological effects on proliferation and differentiation in a variety of malignant cells. The aim of this study was to elucidate the role of the vitamin D receptor (VDR) in butyrate-induced cell differentiation and cell cycle arrest in Caco-2 cells, a human colon cancer cell line. Cell differentiation was evaluated by analyzing the activity of alkaline phosphatase (AP). Protein of VDR, cyclins, cyclin-dependent kinases (cdks) and of cdk inhibitors was quantified by Western blot analysis, VDR-mRNA by PCR. Pre-and postconfluent cells were assessed for VDR binding activity. Cell cycle was analyzed by flow cytometry. Tributyrin significantly increased VDRmRNA level (250% vs. control) and VDR binding activity. Butyrate also enhanced VDR protein content in the nucleus in a re-and dose-dependent manner and more potently than other short-chain fatty acids of a related structure. Both butyrate (640% vs. control) and 1,25-(OH)2D3(350% vs. control) significantly stimulated differentiation, whereas combined treatment with butyrate and 1,25-(OH)2D3resulted in a synergistic amplification of AP activity (1400% vs. control). In the presence of the VDR antagonist ZK 191732, butyrate-induced differentiation was completely abolished (150% vs. control). While butyrate alone increased p21Waf1/Cip1 expression and downregulated cdk 6 and cyclin A, and combined exposure with 1,25-(OH)2D3resulted in a synergistic enhancement of butyrate-induced changes, expressions did not change from control level after treatment with butyrate and ZK 191732. G1 cell cycle arrest induced by butyrate was also abolished after combined treatment with butyrate and ZK 191732. In conclusion, differentiation and cell cycle arrest of Caco-2 cells induced by butyrate are mediated by upregulation of VDR, followed by a stimulation of the negative cell cycle regulator p21Waf1/Cip1 and by a down-regulation of cdk 6 and cyclin A, both involved in cell cycle progression.

Keywords

  • Cell Cycle Arrest
  • Colon Cancer Cell
  • Sodium Butyrate
  • Colon Cancer Cell Growth
  • Negative Cell Cycle Regulator

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-642-55580-0_18
  • Chapter length: 11 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   219.00
Price excludes VAT (USA)
  • ISBN: 978-3-642-55580-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   279.99
Price excludes VAT (USA)
Hardcover Book
USD   349.99
Price excludes VAT (USA)
Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Archer SY, Meng S, Shei A, Hodin RA (1998) p21Waf1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci U S A 95:6791–6796

    PubMed  CrossRef  CAS  Google Scholar 

  • Archer SY, Johnson JJ, Kim J-J, Hodin RA (2001) p21 gene regulation during enterocyte differentiation. J Surg Res 98:4–8

    PubMed  CrossRef  CAS  Google Scholar 

  • Brungs M, Radmark O, Samuelsson B, Steinhilber D (1995) Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor b and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 92:107–111

    PubMed  CrossRef  CAS  Google Scholar 

  • Christman JK, Weich N, Schoenbrunn B, Schneiderman N, Acs G (1980) Hypomethylation of DNA during differentiation of Friend erythroleukemia cells. J Cell Biol 86:366–370

    PubMed  CrossRef  CAS  Google Scholar 

  • Gaschott T, Steinhilber D, Milovic V, Stein J (2001a) Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells. J Nutr 131:1839–1843

    CAS  Google Scholar 

  • Gaschott T, W_chtersh_user A, Steinhilber D, Stein J (2001b) 1,25-Dihydroxycholecalciferol enhances butyrate-induced p21Waf1/Cip1 expression. Biochem Biophys Res Commun 283:80–85

    CrossRef  CAS  Google Scholar 

  • Gaschott T, Werz O, Steinmeyer A, Steinhilber D, Stein J (2001c) Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor. Biochem Biophys Res Commun 288:690–696

    CrossRef  CAS  Google Scholar 

  • Giuliano AR, Franceschi RT, Wood RJ (1991) Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 285:261–269

    PubMed  CrossRef  CAS  Google Scholar 

  • Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH, Gibson PR (2001) Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120:889–899

    PubMed  CrossRef  CAS  Google Scholar 

  • McIntyre A, Gibson PR, Young GP (1993) Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386–391

    PubMed  CrossRef  CAS  Google Scholar 

  • Milovic V, Teller IC, Turchanowa L, Caspary WF, Stein J (2000) Effect of structural analogues of propionate and butyrate on colon cancer cell growth. Int J Colorect Dis 15:264–270

    CrossRef  CAS  Google Scholar 

  • Mørk Hansen C, M_enp PH (1997) EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells. Biochem Pharmacol 54:1173–1179

    CrossRef  Google Scholar 

  • Mørk Hansen C, Binderup L, Hamberg KJ, Carlberg C (2001) Vitamin D and cancer: effects of 1,25-(OH)2D3and its analogs on growth control and tumorigenesis. Front Biosci 6: D820–D848

    CrossRef  Google Scholar 

  • Parker MI, De Haan JB, Gevers W (1986) DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts. J Biol Chem 261:2786–2790

    PubMed  CAS  Google Scholar 

  • Scaglione-Sewell BA, Bissonnette M, Skarosi S, Abraham C, Brasitus TA (2000) A vitamin D3 analog induces a G1-phase arrest in Caco-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 141:3931–3939

    PubMed  CrossRef  CAS  Google Scholar 

  • Scheppach W, Bartram HP, Richter F (1995) Role of short-chain fatty acids in the prevention of colorectal cancer. Eur J Nutr 31A:1077–1080

    CAS  Google Scholar 

  • Schr_der C, Eckert K, Maurer HR (1998) Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. Int J Oncol 13:1335–1340

    Google Scholar 

  • Schr_der O, Heß S, Caspary WF, Stein J (1999) Mediation of differentiating effects of butyrate on the intestinal cell line Caco-2 by transforming growth factor-b1. Eur J Nutr 38:45–50

    CrossRef  Google Scholar 

  • Tanaka Y, Bush KK, Eguchi T, Ikekawa N, Taguchi T, Kobayashi Y, Higgins PJ (1990) Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT- 29 human colonic carcinoma cells and on the reversal of the differentiated phenotype. Arch Biochem Biophys 276:415–423

    PubMed  CrossRef  CAS  Google Scholar 

  • Tanaka Y, Wu AY, Ikekawa N, Iseki K, Kawai M, Kobayashi Y (1994) Inhibition of HT-29 human colon cancer growth under the renal capsule of severe combined immunodeficient mice by an analogue of 1,25-dihydroxyvitamin D3, DD-003. Cancer Res 54:5148–5153

    PubMed  CAS  Google Scholar 

  • Tian JQ, Quaroni A (1999) Involvement of p21(Waf1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation. Am J Physiol 276:C1245–C1258

    PubMed  CAS  Google Scholar 

  • W_chtersh_user A, Stein J (2001) Butyrate-induced differentiation of Caco-2 cells occurs independently from p27. Biochem Biophys Res Commun 281:295–299

    CrossRef  Google Scholar 

  • W_chtersh_user A, Loitsch SM, Stein J (2000a) PPAR-g is selectively upregulated in Caco-2 cells by butyrate. Biochem Biophys Res Commun 272:380–385

    CrossRef  Google Scholar 

  • W_chtersh_user A, Steinhilber D, Loitsch SM, Stein J (2000b) Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation. Biochem Biophys Res Commun 268:778–783

    CrossRef  Google Scholar 

  • Watson J (1933) Butyric acid in the treatment of cancer. Lancet 224:746–748

    CrossRef  Google Scholar 

  • Wu JT, Archer SY, Hinnebusch B, Meng S, Hodin RA (2001) Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation and apoptosis. Am J Physiol 280:G482–G490

    CAS  Google Scholar 

  • Yamamoto H, Soh JW, Shirin H, Xing WQ, Lim JT, Yao Y, Slosberg E, Tomita N, Schieren I, Weinstein IB (1999) Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene 18:103–115

    PubMed  CrossRef  Google Scholar 

  • Yoneda T, Aya S, Sakuda M (1984) Sodium butyrate (SB) augments the effects of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) on neoplastic and osteoblastic phenotype in clonal rat osteosarcoma cells. Biochem Biophys Res Commun 121:796–801

    PubMed  CrossRef  CAS  Google Scholar 

  • Yoshida M, Tanaka Y, Eguchi T, Ikekawa N, Saijo N (1992) Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells. Anticancer Res 12:1947–1952

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Medicine, Johann Wolfgang Goethe University, Frankfurt/Main, Theodor-Stern-Kai 7, 60590, Germany

    Tanja Gaschott

Authors
  1. Tanja Gaschott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautklinik und Poliklinik der Universitätskliniken des Saarlandes, Kirrberger Str., 66421, Homburg/Saar

    Dr. Jörg Reichrath & Prof.Dr. Wolfgang Tilgen & 

  2. Frauenklinik des Universitätsklinikums der Eberhard-Karls-Universität, Calwerstr. 7, 71076, Tübingen

    Dr. Michael Friedrich

Rights and permissions

Reprints and Permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gaschott, T., Stein, J. (2003). Short-Chain Fatty Acids and Colon Cancer Cells: The Vitamin D Receptor—Butyrate Connection. In: Reichrath, J., Tilgen, W., Friedrich, M. (eds) Vitamin D Analogs in Cancer Prevention and Therapy. Recent Results in Cancer Research, vol 164. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55580-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55580-0_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62435-3

  • Online ISBN: 978-3-642-55580-0

  • eBook Packages: Springer Book Archive